Bioequivalence Study of Amoxicillin Dispersible 600 mg Tablets Under Fasting Conditions
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2008-10-23
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 26
- Registration Number
- NCT00778050
- Locations
- 🇺🇸
PRACS Institute Ltd., Fargo, North Dakota, United States
Bioequivalence Study of Metformin Hydrochloride 1000mg Tablets Under Fasting Conditions
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2008-10-23
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 32
- Registration Number
- NCT00778427
- Locations
- 🇺🇸
NovumPharmaceutical Research Services, Las Vegas, Nevada, United States
Bioequivalence Study of Amoxicillin 400 mg/Clavulanic Acid 57 mg Chewable Tablets Under Fed Conditions
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2008-10-23
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 40
- Registration Number
- NCT00778284
- Locations
- 🇺🇸
MDS Pharma Services, Phoenix, Arizona, United States
Bioequivalence Study of Benazepril HCl / Hydrochlorothiazide 20 mg/ 25 mg Tablets Under Fed Conditions
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2008-10-23
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 30
- Registration Number
- NCT00778674
- Locations
- 🇺🇸
aaiPharma, Inc., Chapel Hill, North Carolina, United States
Bioequivalence Study of Metformin HCl 750 mg XR Under Fasting Conditions
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2008-10-23
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 60
- Registration Number
- NCT00778791
- Locations
- 🇺🇸
Gateway medical research, St. Charles, Missouri, United States
Bioequivalence Study of Cefprozil 250 mg/ 5mL Powder For Oral Suspension Under Fasting Conditions
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2008-10-23
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 35
- Registration Number
- NCT00778557
- Locations
- 🇨🇦
Biovail Contract Research, Toronto, Ontario, Canada
Bioequivalence Study of Gabapentin 400 mg Capsules Under Fed Conditions
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2008-10-23
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 24
- Registration Number
- NCT00778765
- Locations
- 🇨🇦
MDS Pharma Services, Saint-Laurent,, Quebec, Canada
Bioequivalence Study of Gabapentin 800 mg Tablets Under Fasting Conditions
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2008-10-23
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 28
- Registration Number
- NCT00778401
- Locations
- 🇺🇸
PRACS Institute Ltd., Fargo, North Dakota, United States
Bioequivalence Study of Fosinopril Sodium/ Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fasting Conditions
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2008-10-23
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 34
- Registration Number
- NCT00777972
- Locations
- 🇺🇸
Gateway Medical Research Inc, St Charles, Missouri, United States
Bioequivalence Study of Furosemide 80mg Tablets Under Fasting Conditions
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2008-10-23
- Lead Sponsor
- Ranbaxy Laboratories Limited
- Target Recruit Count
- 44
- Registration Number
- NCT00778180
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Houston, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath